In 1907, researchers Bernhardt Kronig and Carl Gauss combined the drugs morphine and scopolamine to induce twilight sleep in women during childbirth. Physicians in the early twentieth century in Germany used twilight sleep, Dammerschlaf, to cause women to enter a state of consciousness in which they felt no pain and did not remember giving birth. Twilight sleep was associated with increased use of forceps during delivery, prolonged labor, and increased risk of infant suffocation. Because of those disadvantages, physicians stopped using morphine and scopolamine to prevent pain during childbirth. Morphine and scopolamine were among the first anesthetics to be used during childbirth, and after physicians stopped using them, researchers searched for safer alternatives.

William Smellie helped to incorporate scientific medicine into the process of childbirth in eighteenth century Britain. As a male physician practicing in childbirth and female reproductive health (man-midwife), Smellie developed and taught procedures to treat breech fetuses, which occur when a fetus fails to rotate its head towards the birth canal during delivery. Throughout his career, Smellie compiled a wealth of information about female anatomy in his writings. He modified medical technology such as the obstetrical forceps, an instrument used to maneuver the fetus during childbirth. Smellie's techniques and improvements on forceps alleviated pain in women giving birth, mitigated complications during birth, and reduced infant mortality rates.

In 1873 Italy, Camillo Golgi created the black reaction technique, which enabled scientists to stain and view the structure of neurons, the specialized cells that compose the nervous system. During the nineteenth century, scientists were studying cells and proposed cell theory, which describes the basic characteristics of cells as fundamental units of life. However, cell theory struggled to explain neurons as they are specialized cells and more complex in structure than cells of other tissues. Prior to Golgi’s black reaction, other neuron staining techniques did not enable scientists to clearly and completely view entire neurons without damaging the tissue and obscuring the form. By enabling scientists to study individual neurons and neural tissues, Golgi’s black reaction enables researchers to better study the nervous system and how it develops.

In October 2013, Jürgen Dinger, Sabine Möhner, and Klaas Heinemann published the article “Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring,” hereafter “Cardiovascular Risk,” in the journal Obstetrics and Gynecology. The authors enrolled patients in the study who were new users of either a vaginal contraceptive ring known as NuvaRing or a combined oral contraceptive pill. A combined oral contraceptive pill contains a formulation of the hormones progesterone and estrogen. They followed up with the patients for two to four years after they had started either hormonal contraceptive treatment to record the incidence of specific cardiovascular events. The authors found that the risks of cardiovascular events when starting use of either NuvaRing or a combined hormonal contraceptive pill were similar to each other in the patients they studied. The results of “Cardiovascular Risk” affirmed the results of similar studies and stated that the risk of cardiovascular events was similar in NuvaRing users to other contraceptive users.

The US Food and Drug Administration, or FDA, published the “Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs,” henceforth “Study of Gender Differences,” in July 1993. The document defined acceptable practices for investigators studying new drugs. Prior to 1993, investigators excluded most women from clinical trials because in 1977, the FDA recommended that anyone who could possibly become pregnant be excluded from early phase drug research to minimize risk to a potential fetus. In 1997, the FDA reversed that guidance, advising investigators to include women in early phase drug research, a decision that reflected changing views about a woman’s ability to decide whether to participate in drug trials and furthering research on the effects of drugs on women.

Antoni van Leeuwenhoek was born in Delft, the Netherlands, on 24 October 1632 to Margriet Jacobsdochter van den Berch and Philips Thooniszoon, both of whom were middle-class artisans. He attended grammar school in Warmond, and then temporarily moved to Benthuizen to live with relatives. Eventually Leeuwenhoek left for Amsterdam to work as a cloth merchant's apprentice. Returning to Delft, he married Barbara de Mey on 29 July 1654, and worked as a shopkeeper. The marriage resulted in five children, only one of whom, Maria, outlived Leeuwenhoek.